CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Henry E. Blair, Chairman and Chief Executive Officer of Dyax, will present at the 8th Annual Rodman & Renshaw Healthcare Conference, being held on November 6-8 at the New York Palace Hotel. Mr. Blair will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax Corp. presentation is scheduled for Monday, November 6 at 9:30 am (ET).
